Affiliation: University of Texas Medical Branch
- Primary natural killer/T-cell lymphoma presenting as leptomeningeal diseaseBing Liao
Department of Neuro Oncology, The University of Texas MD Anderson Cancer Center, 1400 Holcombe Boulevard, Room FC7 3000, Unit 431, Houston, TX 77030, United States Department of Neurology, The University of Texas Medical Branch, 301 University Boulevard, Room JSA 9 128, Galveston, TX 77555, United States Electronic address
J Neurol Sci 343:46-50. 2014..Our objective is to report a rare case of primary-CNS-NK/TCL presenting as leptomeningeal disease and to share our diagnostic/therapeutic approach to this rare disease...
- Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALSBing Liao
Department of Neurology, Xiangya Hospital, Central South University, Changsha, 410008, China
Exp Neurol 237:147-52. 2012..Thus, harnessing the neuroprotective potential of microglia may provide novel avenues for ALS therapies...
- Neuroinflammation modulates distinct regional and temporal clinical responses in ALS miceDavid R Beers
Department of Neurology, Methodist Neurological Institute, The Methodist Hospital Research Institute, The Methodist Hospital, Houston, TX 77030, USA
Brain Behav Immun 25:1025-35. 2011....
- Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanismsWeihua Zhao
Department of Neurology, Methodist Neurological Institute, The Methodist Hospital, Houston, TX 77030, USA
Neurobiol Dis 48:418-28. 2012..These data suggest that mSOD1 Tregs contribute to the slowly progressing phase in ALS mice and may offer a novel therapeutic option for ALS patients...
- Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosisDavid R Beers
Department of Neurology, Methodist Neurological Institute, Suite ST 802, 6560 Fannin Street, Houston, TX 77030, USA
Brain 134:1293-314. 2011....
- Atypical neurological complications of ipilimumab therapy in patients with metastatic melanomaBing Liao
Department of Neuro Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas B L, S S, C K M, S T Department of Neurology, The University of Texas Medical Branch, Galveston, Texas B L, S S, C K M
Neuro Oncol 16:589-93. 2014..Our objective is to raise early recognition of atypical neurological adverse events and to share our therapeutic approach...